Target intelligence / Profile preview

Kinesin-associated protein 3 (KIFAP3)

Target
KIFAP3
Molecular classification
Other (kinesin-associated accessory protein; not a receptor, enzyme, transporter, or ion channel)
01

Overview

Kinesin-associated protein 3 (KIFAP3, KAP3) is a non-motor, accessory subunit of the heterotrimeric kinesin-2 motor protein complex, which consists of KIF3A/B or KIF3C and KAP3 itself. It oligomerizes with KIF3A and KIF3B or KIF3C to mediate microtubule-dependent intracellular trafficking of various cargoes, including the tumor suppressor APC, endocytic receptors, and neuronal proteins. KIFAP3 is essential for processes such as mitosis (including spindle assembly and chromosome segregation), endosomal/lysosomal localization, and neuronal axonal transport. It contains multiple 'Armadillo' repeats and interacts with regulatory proteins such as smg GDS, thereby playing a role in regulating the membrane binding of small G proteins. Variants and altered expression of KIFAP3 have been associated with increased survival in ALS, and KIFAP3 may be important in both neurodegenerative disease mechanisms and cancer biology. KIFAP3 is not itself a direct therapeutic target, and no drugs are known to act on it directly at this time.

Other names
KAP3KIF3APSMAPKAP-3FLA3KAP-1Smg GDS-associated proteindJ190I16.1small G protein GDP dissociation stimulatorsmg GDS
02

Biological functions

Intracellular transportChromosome movementMitosis (spindle formation and chromosome segregation)Signal transduction (regulates small G proteins including Rho and Rap1 families)Endosome and lysosome localizationNeuronal cargo trafficking
03

Disease associations

Neurodegenerative disease (implicated in amyotrophic lateral sclerosis/ALS, frontotemporal dementia)Cancer (interacts with tumor suppressor APC, relates to cell adhesion and motility in cancer)Other (e.g., involvement in mitosis)
04

Safety considerations

No known targeted pharmacological safety concerns, as KIFAP3 is not a general therapeutic target
05

Biomarkers

SNP rs1541160 in KIFAP3 associated with survival in sporadic ALSExpression levels of KIFAP3 may serve as a marker in ALS progression in model systems

Beyond the preview

Go deeper on Kinesin-associated protein 3 (KIFAP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinesin-associated protein 3 (KIFAP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call